Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ APITD1 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA524846
Description
This antibody is predicted to react with bovine based on sequence homology.
APITD1 was identified in the neuroblastoma tumour suppressor candidate region on chromosome 1p36. It contains a TFIID-31 domain, similar to that found in TATA box-binding protein-associated factor, TAF(II)31, which is required for p53-mediated transcription activation. This gene was expressed at very low levels in neuroblastoma tumours, and was shown to reduce cell growth in neuroblastoma cells, suggesting that it may have a role in a cell death pathway.
Specifications
APITD1 | |
Polyclonal | |
Unconjugated | |
CENPS | |
2610040C18Rik; 2810407L01Rik; APITD1; APITD1-CORT; APITD1-CORT protein; APITD1-CORT readthrough; apoptosis-inducing TAF9-like domain-containing protein 1; Apoptosis-inducing TAF9-like domain-containing protein 1 homolog; apoptosis-inducing, TAF9-like domain 1; CENPS; CENP-S; Centromere protein S; FAAP16; FANCM-associated histone fold protein 1; FANCM-interacting histone fold protein 1; Fanconi anemia-associated polypeptide of 16 kDa; MHF1; ortholog of human apoptosis-inducing, TAF9-like domain 1 APITD1 | |
Rabbit | |
Antigen affinity chromatography, Protein A | |
RUO | |
378708, 69928 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Flow Cytometry, Immunohistochemistry (Paraffin), Western Blot | |
0.5 mg/mL | |
PBS with 0.09% sodium azide; pH 7.4 | |
Q8N2Z9, Q9D084 | |
CENPS | |
KLH conjugated synthetic peptide between 48-74 amino acids from the central region of human APITD1. | |
400 μL | |
Primary | |
Human, Mouse | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction